Palmitoylethanolamide (PEA): A promising biomarker for coronary dysfunction in MOB individuals.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.04.098
Abstract: Article history: Received 27 February 2017 Received in revised form 11 March 2017 Accepted 26 April 2017 ed. Secondly, the evidence of PEA associated with disease severity was unwarranted. Finally, the cost-effectiveness of PEA as… read more here.
Keywords: pea promising; promising biomarker; biomarker; palmitoylethanolamide pea ... See more keywords